BioSpace News Archive

The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.39 per share.

IntelGenx Technologies Corp. announces the closing of an offering by way of private placement to certain investors in the United States of U.S.$1.2 million principal amount of 8% convertible notes due October 15, 2024.

Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, reported financial results for its second quarter ending June 30, 2020 and provided an update on its operations.

Tarsus Pharmaceuticals, Inc. announced the pricing of its initial public offering of 5,500,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $88.0 million, before underwriting discounts, commissions, and offering expenses payable by Tarsus.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, announced the pricing of its upsized initial public offering of 10,000,000 shares of common stock at a public offering price of $19.00 per share.

Aligos Therapeutics, Inc. announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share.